BioClinica acquires patient recruitment, retention firm MediciGroup

By Zachary Brennan

- Last updated on GMT

BioClinica acquires patient recruitment, retention firm MediciGroup

Related tags Clinical trial Patient

Specialty trials services and tech provider BioClinica has acquired the patient recruitment and retention firm, MediciGroup. Financial terms of the deal were not disclosed. 

BioClinica will look to leverage Medici’s specialized services, including its ability to recruit and retain orphan disease and unique patient populations for hard-to-recruit trials.

Medici’s 40 employees will relocate to BioClinica’s Audobon facility in January, BioClinica CEO John Hubbard told Outsourcing-Pharma.com.

Hubbard added: “Medici will bring an array of digital and specialized patient recruitment and retention services to BioClinica’s global clinical trial network (CCBR) and other service and technology offerings such as patient insights, patient locate services and more.  Additionally, analytics are fundamental to both companies…This acquisition provides a solution to recruiting patients faster, more efficiently and brings the most qualified patient in to trials, including hard to find patients​.” 

The acquisition includes MediciGroup affiliates MediciGlobal, and Access to Patients, and includes a lost-to-follow-up patient locate service that finds missing patients globally.  Medici also manages over 30 global patient communities online and has implemented more than 200 programs for some of the world’s largest pharma companies since 1992. 

BioClinica and Medici have already worked together on studies where the Medici Global team has leveraged data from BioClinica’s technology, and most recently their collaborations helped a company complete enrollment for a global study ahead of schedule.

Liz Moench, founder and CEO, Medici, added: “Together with BioClinica, our services will deliver an important model focused on speed, quality and cost efficiency for clinical trials implementation…When we integrate our recruitment metrics with BioClinica’s system, we can manage clinical trials in real time. This enables us to monitor enrollment rates by sites and drive performance at all levels – recruitment marketing and site performance from start to end​.”

Moench will lead the BioClinica’s global patient recruitment and retention services at the company’s Pennsylvania-based headquarters.

Related news

Show more

Related products

show more

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

cGMP Assurance of Supply Services Case Study

cGMP Assurance of Supply Services Case Study

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Apr-2023 | Case Study

Having the right raw materials available for production when they’re needed is imperative, as delays can negatively impact production schedules. Manufacturers...

Related suppliers

Follow us

Products

View more

Webinars